论文部分内容阅读
弥漫性血管内凝血 (DIC)是多种疾病和致病因素引起的临床综合征 ,为内科较常见的病症 ,尤其是急性白血病(AL ) ,如不及时治疗 ,病死率高 ,补充凝血因子的治疗是不可少的。但靠输注全血及血浆疗效不满意 ,为此在常规治疗的基础上给予凝血酶原复合物 (PCC)及纤维蛋白原制剂 (Fg)
Diffuse intravascular coagulation (DIC) is a clinical syndrome caused by a variety of diseases and pathogenic factors. It is a more common medical condition, especially acute leukemia (AL). If not treated promptly, the mortality rate is high. Coagulation factor Treatment is essential. But by the infusion of whole blood and plasma efficacy is not satisfied, for this purpose in the conventional treatment given prothrombin complex (PCC) and fibrinogen preparation (Fg)